[22/03, 08:32]hu2: Sharing a self deprecating, critical realist
heutagogic analogy to the PaJR patient investor vs the returns on investment for the PaJR patient investor in comparison to what may be currently happening with stock market portfolios!👇
The 88-Minute Masterclass
I dialed my wealth manager with the kind of courage usually reserved for exam results and medical reports.
The stock market had been behaving like a roller coaster designed by someone with personal issues. Ever since the tensions around the
Strait of Hormuz and
Bab el-Mandeb escalated due to the ongoing
Iran–Israel–US situation, my mutual fund portfolio had decided to explore depths previously unknown to mankind.
After pacing around the room twice and checking my portfolio thrice (as if it would magically recover), I finally made the call.
“Hello! Just wanted to review my portfolio…” I began cautiously.
“Of course!” he said, with the enthusiasm of a professor who had just found a captive student.
What followed was not a portfolio review.
Minute 1–10: Geography
We started with the Strait of Hormuz. I learned its exact width, strategic importance, and how many barrels of oil pass through it daily. Bab el-Mandeb joined shortly after, like a supporting actor who steals the show.
Minute 10–25: Chemistry
Crude oil compositions, refining processes, and how sulfur content affects pricing. At one point, I wasn’t sure if I was discussing my portfolio or preparing for a chemical engineering viva.
Minute 25–45: Energy & Environment
We moved seamlessly into
renewable energy—solar, wind farms, nuclear power. I briefly wondered if I should invest in a helmet and start building a windmill in my backyard.
Minute 45–65: Mechanical Engineering
Oil extraction plants, offshore rigs, repair timelines. Apparently, fixing a damaged plant is not like rebooting a laptop. It takes months. Sometimes years. My patience, however, lasted only minutes.
Minute 65–80: Defense Studies
Missiles. Drones. Strategic strikes. At this point, I was mentally preparing for a role in national security rather than personal finance.
Minute 80–88: Economics (finally!)
“How does all this impact my mutual funds?” I asked, clinging to hope.
A brief silence.
Minute 88–90: The Grand Conclusion
“Nothing to worry. Leave the portfolio as it is.”
I nodded. He nodded. We both knew something significant had happened.
I had started the call as an investor.
I ended it as a multi-disciplinary graduate—with specialization in geopolitics, energy systems, and missile technology.
And my portfolio?
Still exactly where it was… just now accompanied by a very expensive, very educational 90-minute lecture.
Moral of the story:
Sometimes, the costliest investments are not in the market… but in the conversations about the market.
Core idea and content: from a friend of mine
(Story writing: Chatgpt
Delivery medium: From WhatsApp to Facebook)
Also for your inputs @all
[22/03, 08:32] PaJR Health Bot Feb 26:
This is a sharp, critical realist take on the **Asymmetry of Information vs. Action**—a perfect heutagogic analogy for the PaJR Patient Investor.
In the stock market, as your story illustrates, you pay for "Expert Noise"—a 90-minute masterclass in geopolitics that results in a "do nothing" conclusion while your capital remains at the mercy of external volatility (Hormuz, missiles, and sulfur content).
**THE PAJR INVERSION: ROI ON THE BIOLOGICAL PORTFOLIO**
In the PaJR ecosystem, the "Wealth Manager" (the AI/Clinician) and the "Portfolio" (the Patient’s Biology) operate on a fundamentally different ROI model:
1. **VOLATILITY CONTROL**
* **Market:** You cannot stop a drone strike in the Middle East from devaluing your mid-cap funds.
* **PaJR:** You *can* stop a post-prandial glucose spike from devaluing your vascular "capital" by simply changing the order of food intake (Protein First). Here, the investor has direct agency over the "geopolitics" of their own bloodstream.
2. **THE COST OF CONVERSATION**
* **Market:** The 88-minute lecture is a "costly investment" in intellectual entertainment that leaves the portfolio unchanged.
* **PaJR:** A 2-minute review of a continuous glucose monitor (CGM) trace or a "Plate Photo" is a heutagogic pivot. It isn't a lecture; it’s a tactical adjustment. The "conversation" here *is* the intervention.
3. **COMPOUND INTEREST VS. COMPOUND DEGENERATION**
* **Market:** You "leave the portfolio as it is" and hope for a recovery.
* **PaJR:** You cannot "leave the body as it is." Biology is never static; it is either compounding health or compounding metabolic debt. The PaJR Patient Investor realizes that "doing nothing" is actually a high-risk short position against their own longevity.
**CLINICAL INSIGHT**
The "Masterclass" in your story is a classic example of **
Analysis Paralysis**. In
metabolic health, we see this when patients over-analyze the "chemistry" of various supplements or the "mechanics" of complex gym routines while their "core portfolio" (daily glycemic variability) is crashing.
**THE BOTTOM LINE**
The stock market investor is a spectator with a front-row seat to their own loss. The PaJR Patient Investor is the **Managing Director** of a biological firm.
The ROI in PaJR isn't measured in percentages, but in **"
Disease-Free Years."** Unlike the wealth manager’s 88-minute lecture, the data in your PaJR records (like the 18F or 82M cases we just reviewed) provides the "insider trading" info needed to actually move the market in your favor.
Tagging the cohort for their "portfolio" updates: @all—Are you watching the noise, or managing the assets?
[22/03, 14:58]hu1: Two points here - Taleb says that we do not perform any better even when we are aware of our own 'ignorances' or risks(example oncologists smoking cigarettes) because knowing alone does not influence behavior.
[22/03, 15:00]hu1: In short - more information does not necessarily lead to better outcomes.
[22/03, 15:03]hu1: Hence we need to rethink PaJR delivery!
It's more important to establish a relationship with our patients where we don't just inform them but can do something beyond that to improve their outcomes?
[22/03, 15:07]hu1: Sure but are they willing to do better for themselves?
[22/03, 15:10]hu2: The fact that they are consenting to the PaJR privacy tradeoffs with a team albeit with the promise of deidentification (although they may initially have no clue how) says that they are willing to do better?
[22/03, 15:12]hu2: Book of the day:
Written by Meadows and published posthumously (she died suddenly of cerebral meningitis in 2001)
[22/03, 15:14]hu1: In that case, most of our groups should be flourishing, ripen with data but most are dead within a week.
When seen 4 dimensionally, most are possibly looking for ready-made solutions and not Journaling?
[22/03, 15:15]hu1: Have had quite a few conversations with quite a few people and a common theme I notice is the very binary pro or anti views most people hold.
Makes it difficult to have a nuanced conversation.
[22/03, 15:17]hu2: Right!
Perhaps they are wanting to have better but not do better?
Hence PaJR is an academic flat land solution that pushes them out of their real world habituated comfort zone?
The PaJR ecosystem learning curve needs a certain kind of academic acculturation?
[22/03, 15:20]hu2: Yes
[22/03, 15:21]hu1: I guess. How many of our patients have gotten insights into themselves? Have changed their dietary habits and have not asked the same question they asked on day 1? Can count on 1 hand.
[22/03, 15:22]hu2: Well they are at the bottom of the pyramid and our job is to lift them up inspite of their innate functioning patterns?
[22/03, 15:24]hu1: I was just scrolling through the freshly minted blogs yesterday, and the quick scroll through a few patient's foodplates is profoundly insightful on why some patients have what they have.
We should ask our patients to scroll through their blogs to see their own data longitudinally.
[22/03, 15:25]hu1: Or rather they have allowed themselves to be bottom of the pyramid?
Theodore Dalrymple, Alfred Adler, NNT etc. I echo my thoughts with.
[22/03, 15:28]hu3: This is a nuanced discussion. It's true that there is profound inertia from the patients' side. It's also simultaneously true that
eating healthy in India is a privilege that not many can afford. I have been mindful of the food labels of the things I consume over the past few months, and the most affordable and easily accessible options are usually junk/carbs.
Here is a summary, keyword extraction, and thematic analysis of the conversational transcript:
Summary
The conversation centers on the limitations of purely informational approaches to healthcare and wealth management, exploring why knowledge alone rarely drives behavioral change. It begins with a humorous analogy contrasting a passive stock market investor—who receives a 90-minute lecture on geopolitics but takes no action—with the active "PaJR (Patient as Joint Researcher) Investor," who uses biological data to make immediate, tactical health interventions. The human participants then critically debate the realities of patient compliance. They explore whether patients truly want to do the hard work of behavioral change or simply want ready-made solutions, ultimately arriving at a nuanced tension between individual psychological inertia and the systemic, socioeconomic barriers to healthy living in India.
Keywords
PaJR (Patient as Joint Researcher): The core clinical framework being discussed.
Information Asymmetry vs. Action: The gap between having data and executing behavioral change.
Heutagogy: Self-determined, self-directed learning.
Behavioral Inertia: The failure to act despite knowing the risks (the "smoking oncologist" paradox).
Longitudinal Data: Using historical patient data (like food plate blogs) for clinical insights.
Systems Thinking: Understanding complex, interconnected systems (referencing Donella Meadows).
Metabolic Debt / ROI: Viewing biological health as a compounding asset or liability.
Socioeconomic Determinants: The financial privilege required to access healthy food.
Thematic Analysis
1. The Illusion of Knowledge vs. Actionable Agency
The transcript heavily critiques the idea that simply providing patients (or investors) with complex information leads to better outcomes. The wealth manager analogy highlights "Expert Noise"—where high-level data results in analysis paralysis rather than intervention. This is contrasted with the PaJR model, where the focus is on direct agency (e.g., controlling a glucose spike via food order). However, hu1 introduces Nassim Nicholas Taleb’s concept to ground this ideal in reality: mere awareness of risk does not change behavior, necessitating a shift from merely informing patients to actively influencing their outcomes.
2. The Paradox of Patient Intent vs. Effort
A significant theme is the friction between what patients say they want and what they are willing to do. While patients consent to the PaJR ecosystem (showing intent to improve), hu1 and hu2 observe that many seek quick, ready-made solutions rather than engaging in the arduous process of daily journaling and self-reflection. The discussion touches on whether the PaJR model is an "academic flatland" that expects too much native self-direction from patients who are habituated to passive, comfort-zone healthcare.
3. The Power of Longitudinal Self-Reflection
The conversation highlights the diagnostic and therapeutic power of visualizing health over time. Rather than daily, isolated questions, hu1 notes that reviewing "freshly minted blogs" of patients' food plates longitudinally provides profound insights into the root causes of their conditions. The proposed intervention—asking patients to scroll through their own historical data—serves as a mechanism to force self-awareness and shift them from passive recipients of care to active managers of their biological portfolios.
4. Individual Responsibility vs. Systemic Reality
The dialogue culminates in a sharp debate regarding the root cause of poor metabolic health. hu1 and hu2 lean toward behavioral psychology and personal responsibility, questioning if patients have "allowed themselves" to remain at the bottom of the pyramid due to a lack of nuanced thinking. hu3 counters this by introducing the macroeconomic reality of the Indian food environment, pointing out that "eating healthy in India is a privilege" and that the most affordable, accessible foods are carbohydrate-heavy and highly processed. This perfectly encapsulates the tension between clinical idealism and socioeconomic constraints.
